The Bradykinin Symposium 2022 and the Angioedema School 2022 will be supported by the urticaria network e.V. (UNEV) and an unrestricted educational grant by Takeda.
UNEV - The urticaria network is an association of people who share the goal of promoting research on the clinical picture for urticaria, and for improving the level of care for patients with urticaria. UNEV promotes projects, campaigns, and research proposals to research into the causes and treatment of urticaria, or inform urticaria patients about their illness.
Takeda Pharmaceutical Company Limited
The Global Allergy and Asthma European Network - GA²LEN, is a consortium of leading European research centres specialized in allergic diseases, which include asthma. Funded by the European Union under the 6th framework programme, GA²LEN addresses the growing public health concern of allergic diseases.
European Centre for Allergy Research Foundation (ECARF, founded in 2003) supports nationwide structured research in the field of allergies, the dissemination of the highest quality and knowledge for physicians and the general public as well as initiatives to improve medical care of allergic diseases. Moreover ECARF supports activities to improve the quality of life for people suffering from allergies.
The International Center for Angioedema Research (icare) was founded in 2011 at the Department of Dermatology at the Charité with the aim of improving treatment in the long term for angioedema patients. The center would like all patients to receive the best possible diagnosis and treatment, and offer extensive advice in all aspects, in order to continue achieving significant improvements for these patients.